Kohei Kumegawa

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 14

Top Topics

Positive Breast Cancer

Endoplasmic Reticulum

Estrogen Receptor

Top Venues

British journal of cancer

Cancer gene therapy

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Liying Yang, Kohei Kumegawa, Sumito Saeki, Tomoyoshi Nakadai, Reo Maruyama
Identification of lineage-specific epigenetic regulators FOXA1 and GRHL2 through chromatin accessibility profiling in breast cancer cell lines. Cancer gene therapy (2024)
Liying Yang, Kohei Kumegawa, Sumito Saeki, Tomoyoshi Nakadai, Reo Maruyama
Identification of lineage-specific epigenetic regulators FOXA1 and GRHL2 through chromatin accessibility profiling in breast cancer cell lines. Cancer gene therapy 31 (5) (2024)
Liying Yang, Kohei Kumegawa, Sumito Saeki, Tomoyoshi Nakadai, Reo Maruyama
Identification of lineage-specific epigenetic regulators FOXA1 and GRHL2 through chromatin accessibility profiling in breast cancer cell lines. Cancer gene therapy 31 (5) (2024)
Liying Yang, Kohei Kumegawa, Sumito Saeki, Tomoyoshi Nakadai, Reo Maruyama
Identification of lineage-specific epigenetic regulators FOXA1 and GRHL2 through chromatin accessibility profiling in breast cancer cell lines. Cancer gene therapy 31 (5) (2024)
Liying Yang, Kohei Kumegawa, Sumito Saeki, Tomoyoshi Nakadai, Reo Maruyama
Identification of lineage-specific epigenetic regulators FOXA1 and GRHL2 through chromatin accessibility profiling in breast cancer cell lines. Cancer gene therapy 31 (5) (2024)
Kohei Kumegawa, Sumito Saeki, Yoko Takahashi, Liying Yang, Tomo Osako, Tomoyoshi Nakadai, Sayuri Amino, Tetsuyo Maeda, Chikako Takahata, Seiichi Mori, Tetsuo Noda, Shinji Ohno, Takayuki Ueno, Reo Maruyama
Correction: Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility. British journal of cancer (2023)
Kohei Kumegawa, Sumito Saeki, Yoko Takahashi, Liying Yang, Tomo Osako, Tomoyoshi Nakadai, Sayuri Amino, Tetsuyo Maeda, Chikako Takahata, Seiichi Mori, Tetsuo Noda, Shinji Ohno, Takayuki Ueno, Reo Maruyama
Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility. British journal of cancer (2023)
Kohei Kumegawa, Sumito Saeki, Yoko Takahashi, Liying Yang, Tomo Osako, Tomoyoshi Nakadai, Sayuri Amino, Tetsuyo Maeda, Chikako Takahata, Seiichi Mori, Tetsuo Noda, Shinji Ohno, Takayuki Ueno, Reo Maruyama
Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility. British journal of cancer (2023)
Miwa Tanaka, Surachada Chuaychob, Mizuki Homme, Yukari Yamazaki, Ruyin Lyu, Kyoko Yamashita, Keisuke Ae, Seiichi Matsumoto, Kohei Kumegawa, Reo Maruyama, Wei Qu, Yohei Miyagi, Ryuji Yokokawa, Takuro Nakamura
ASPSCR1::TFE3 orchestrates the angiogenic program of alveolar soft part sarcoma. Nature communications 14 (1) (2023)
Kohei Kumegawa, Sumito Saeki, Yoko Takahashi, Liying Yang, Tomo Osako, Tomoyoshi Nakadai, Sayuri Amino, Tetsuyo Maeda, Chikako Takahata, Seiichi Mori, Tetsuo Noda, Shinji Ohno, Takayuki Ueno, Reo Maruyama
Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility. British journal of cancer (2023)
Joo Mi Yi, Tae-Hong Kang, Yu Kyeong Han, Ha Young Park, Ju Hwan Yang, Jin-Han Bae, Jung-Soo Suh, Tae-Jin Kim, Joong-Gook Kim, Yan-Hong Cui, Hiromu Suzuki, Kohei Kumegawa, Sung Joo Kim, Yi Zhao, In Ja Park, Seung-Mo Hong, Joon-Yong Chung, Su-Jae Lee
Human Neuralized is a novel tumour suppressor targeting Wnt/β-catenin signalling in colon cancer. EMBO reports (2023)
Kohei Kumegawa, Sumito Saeki, Yoko Takahashi, Liying Yang, Tomo Osako, Tomoyoshi Nakadai, Sayuri Amino, Tetsuyo Maeda, Chikako Takahata, Seiichi Mori, Tetsuo Noda, Shinji Ohno, Takayuki Ueno, Reo Maruyama
Correction: Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility. British journal of cancer (2023)
Kohei Kumegawa, Sumito Saeki, Yoko Takahashi, Liying Yang, Tomo Osako, Tomoyoshi Nakadai, Sayuri Amino, Tetsuyo Maeda, Chikako Takahata, Seiichi Mori, Tetsuo Noda, Shinji Ohno, Takayuki Ueno, Reo Maruyama
Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility. British journal of cancer (2023)
Hiroshi Kitajima, Reo Maruyama, Takeshi Niinuma, Eiichiro Yamamoto, Akira Takasawa, Kumi Takasawa, Kazuya Ishiguro, Akihiro Tsuyada, Ryo Suzuki, Gota Sudo, Toshiyuki Kubo, Kei Mitsuhashi, Masashi Idogawa, Shoichiro Tange, Mutsumi Toyota, Ayano Yoshido, Kohei Kumegawa, Masahiro Kai, Kazuyoshi Yanagihara, Takashi Tokino, Makoto Osanai, Hiroshi Nakase, Hiromu Suzuki
TM4SF1-AS1 inhibits apoptosis by promoting stress granule formation in cancer cells. Cell death & disease 14 (7) (2023)